US1032805A
(en)
|
1903-03-11 |
1912-07-16 |
Miller O A Treeing Machine Co |
Shoe-form.
|
US4851423A
(en)
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
AU3102697A
(en)
|
1996-06-19 |
1998-01-07 |
Rhone-Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
AU735366B2
(en)
|
1997-09-29 |
2001-07-05 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
BR9910864A
(pt)
|
1998-06-04 |
2002-02-05 |
Abbott Lab |
Compostos anti-inflamatórios para inibição de aderência celular
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
WO2000075145A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
AU6076000A
(en)
|
1999-07-30 |
2001-02-19 |
Vertex Pharmaceuticals Incorporated |
Cyclic amine derivatives for the treatment of neurological diseases
|
WO2001014336A1
(fr)
|
1999-08-20 |
2001-03-01 |
Nippon Kayaku Kabushiki Kaisha |
Derives benzeniques substitues par un cycle aromatique, et leur procede de production
|
AU2001264313A1
(en)
|
2000-06-20 |
2002-01-02 |
Japan Tobacco Inc. |
Pyrazolopyridine compounds and use thereof as drugs
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
IL156827A0
(en)
|
2001-02-20 |
2004-02-08 |
Chugai Pharmaceutical Co Ltd |
Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
|
WO2002070491A1
(fr)
|
2001-03-01 |
2002-09-12 |
Shionogi & Co., Ltd. |
Derive a noyau heteroaromatique azote presentant une activite d'inhibiteur d'integrase du vih
|
WO2002083628A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused compounds
|
WO2002096426A1
(en)
|
2001-05-25 |
2002-12-05 |
Bristol-Myers Squibb Company |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
AU2002322585A1
(en)
|
2001-07-20 |
2003-03-03 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
US7294624B2
(en)
|
2001-12-20 |
2007-11-13 |
Bristol Myers Squibb Company |
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
|
US20030236277A1
(en)
*
|
2002-02-14 |
2003-12-25 |
Kadow John F. |
Indole, azaindole and related heterocyclic pyrrolidine derivatives
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
MXPA04010523A
(es)
|
2002-04-25 |
2005-06-08 |
Ono Pharmaceutical Co |
Compuestos derivados de dicetohidrazina y medicamentos que los contienen como ingrediente activo.
|
US7368578B2
(en)
|
2002-09-10 |
2008-05-06 |
Takeda Pharmaceutical Company Limited |
Five-membered heterocyclic compounds
|
EP1537105A2
(en)
|
2002-09-13 |
2005-06-08 |
Synta Pharmaceuticals Corporation |
Synthesis of indolizines
|
EP1541574A4
(en)
|
2002-09-18 |
2007-06-20 |
Ono Pharmaceutical Co |
TRIAZASPIRO DERIVATIVES 5.5 | UNDECANS AND DRUGS CONTAINING THEM AS AN ACTIVE INGREDIENT
|
US20060019977A1
(en)
|
2002-10-18 |
2006-01-26 |
Ono Pharmaceutical Co., Ltd. |
Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient
|
EP1581496A4
(en)
|
2002-12-02 |
2008-04-23 |
Gilead Sciences Inc |
2-SUBSTITUTED 3-PROPENAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
WO2004082606A2
(en)
|
2003-03-13 |
2004-09-30 |
Synta Pharmaceuticals Corp. |
Fused pyrrole compounds
|
EP1479676A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
Benzimidazole-derivatives as factor xa inhibitors
|
WO2005023761A2
(en)
|
2003-09-11 |
2005-03-17 |
Kemia, Inc. |
Cytokine inhibitors
|
EP1675830A4
(en)
|
2003-09-30 |
2008-08-20 |
Scios Inc |
HETEROCYCLIC AMIDES AND SULFONAMIDES
|
CA2542514A1
(en)
|
2003-10-23 |
2005-05-06 |
Pharmacia Corporation |
Pyrimidine compounds for the treatment of inflammation
|
EP1678168B1
(en)
|
2003-10-24 |
2012-07-11 |
Exelixis, Inc. |
P70s6 kinase modulators and method of use
|
US20050137187A1
(en)
|
2003-12-23 |
2005-06-23 |
Souers Andrew J. |
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
|
US7049307B2
(en)
|
2003-12-23 |
2006-05-23 |
Abbott Laboratories |
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
|
US7071182B2
(en)
|
2003-12-23 |
2006-07-04 |
Abbott Laboratories |
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
|
US20050137243A1
(en)
|
2003-12-23 |
2005-06-23 |
Souers Andrew J. |
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
|
PE20051141A1
(es)
*
|
2004-02-20 |
2006-01-30 |
Boehringer Ingelheim Int |
Inhibidores de la polimerasa viral
|
KR20060129077A
(ko)
|
2004-03-09 |
2006-12-14 |
베링거 인겔하임 파마슈티칼즈, 인코포레이티드 |
만성 염증 질환을 치료하기 위한 사이토킨 생성억제제로서의3-'4-헤테로사이클릴-1,2,3-트리아졸-1-일-n-아릴-벤즈아미드
|
WO2005099824A1
(en)
|
2004-03-30 |
2005-10-27 |
Synta Pharmaceuticals, Corp. |
1-glyoxylamide indolizines for treating lung and ovarian cancer
|
US7632813B2
(en)
|
2004-04-26 |
2009-12-15 |
Ono Pharmaceutical Co., Ltd. |
Bone densifying agent characterized by use of cathepsin K inhibitor with PTH
|
CN101437524B
(zh)
*
|
2004-09-14 |
2012-01-11 |
法莫赛特股份有限公司 |
2'-氟-2'-烷基-取代的或其它任选取代的呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
US7531560B2
(en)
|
2004-11-10 |
2009-05-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Anti-cytokine heterocyclic compounds
|
JP2008527031A
(ja)
|
2005-01-19 |
2008-07-24 |
バイオリポックス エービー |
炎症の治療に有用なピロロピリジン誘導体
|
GB0503054D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
WO2006091862A2
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Cytokine inhibitors and their use in therapy
|
US20080214527A1
(en)
|
2005-08-04 |
2008-09-04 |
Takashi Kawasuji |
Hiv Integrase Inhibitors
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
WO2007031791A1
(en)
|
2005-09-16 |
2007-03-22 |
Arrow Therapeutics Limited |
Biphenyl derivatives and their use in treating hepatitis c
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
SI2343299T1
(sl)
|
2005-12-13 |
2016-06-30 |
Incyte Holdings Corporation |
S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b) pirimidini kot zaviralci janus kinaze
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
EP1867648A1
(en)
|
2006-06-13 |
2007-12-19 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
|
EP1870410A1
(en)
|
2006-06-13 |
2007-12-26 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
JP4999923B2
(ja)
|
2006-06-13 |
2012-08-15 |
中国科学院上海薬物研究所 |
複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物
|
EP1867647A1
(en)
|
2006-06-13 |
2007-12-19 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
|
TW200815437A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
TW200815438A
(en)
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
US8158810B2
(en)
|
2006-07-27 |
2012-04-17 |
Gilead Sciences, Inc. |
ALDH-2 inhibitors in the treatment of addiction
|
EP1900739A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Diazolodiazine derivatives as kinase inhibitors
|
US20090062273A1
(en)
|
2006-12-15 |
2009-03-05 |
Ingo Hartung |
3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same.
|
EP1932845A1
(en)
|
2006-12-15 |
2008-06-18 |
Bayer Schering Pharma Aktiengesellschaft |
3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
WO2008091681A2
(en)
|
2007-01-23 |
2008-07-31 |
Housey Gerard M |
Theramutein modulators
|
DK2134689T3
(da)
|
2007-03-16 |
2014-06-30 |
Scripps Research Inst |
Inhibitorer af fokal adhæsionskinase
|
BRPI0809992A2
(pt)
|
2007-04-02 |
2014-10-14 |
Palau Pharma Sa |
Derivados de pirrolopirimidina
|
WO2008124848A1
(en)
|
2007-04-10 |
2008-10-16 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
NZ582090A
(en)
|
2007-06-29 |
2012-05-25 |
Gilead Sciences Inc |
Purine derivatives and their use as modulators of toll-like receptor 7
|
WO2009014910A2
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
|
EP2188272B1
(en)
|
2007-08-06 |
2016-02-24 |
reMynd NV |
Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
|
WO2009034433A2
(en)
|
2007-09-10 |
2009-03-19 |
Glenmark Pharmaceuticals, S.A. |
3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
|
CN101861151B
(zh)
|
2007-09-14 |
2014-08-13 |
梅特希尔基因公司 |
使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗
|
CN101910170A
(zh)
|
2007-10-22 |
2010-12-08 |
记忆药物公司 |
用于治疗疾病的烟碱性乙酰胆碱受体的(1,4-二氮杂双环[3.2.2]壬-6-烯-4-基)-杂环基-甲酮配体
|
CA2705583A1
(en)
|
2007-11-29 |
2009-06-04 |
Boehringer Ingelheim International Gmbh |
Derivatives of 6,7-dihydro-5h-imidazo[1,2-.alpha.]imidazole-3-carboxylic acid amides
|
EP2070929A1
(en)
|
2007-12-11 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
RU2544856C2
(ru)
|
2008-01-25 |
2015-03-20 |
Сергей Олегович Бачурин |
НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
EP2285216A4
(en)
|
2008-02-21 |
2012-09-19 |
Sequoia Pharmaceuticals Inc |
HIV PROTEASE INHIBITOR AND COMBINED CYTOCHROME P450 INHIBITOR
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2009133834A1
(ja)
|
2008-04-28 |
2009-11-05 |
塩野義製薬株式会社 |
血管内皮リパーゼ阻害活性を有するケトアミド誘導体
|
US20090298834A1
(en)
|
2008-06-02 |
2009-12-03 |
Hassan Pajouhesh |
4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
|
US20110294836A1
(en)
|
2008-06-20 |
2011-12-01 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
EA022669B1
(ru)
|
2008-07-08 |
2016-02-29 |
Инсайт Холдингс Корпорейшн |
1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
FR2934593B1
(fr)
|
2008-07-29 |
2010-09-10 |
Pf Medicament |
Derives dimeriques d'artemisinine et application en therapie anticancereuse
|
US8242106B2
(en)
|
2008-08-01 |
2012-08-14 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
CA2734651A1
(en)
|
2008-08-21 |
2010-02-25 |
Richter Gedeon Nyrt. |
Methods for treating neuropathic pain
|
CA2736970A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Pyrimidinone derivatives for use as medicaments
|
WO2010034740A1
(en)
|
2008-09-23 |
2010-04-01 |
Palau Pharma, S.A. |
(r)-3-(n,n-dimethylamino)pyrrolidine derivatives
|
DK2358720T3
(en)
|
2008-10-16 |
2016-06-06 |
Univ California |
Heteroarylkinaseinhibitorer fused-ring
|
WO2010053998A1
(en)
|
2008-11-05 |
2010-05-14 |
Xenon Pharmaceuticals, Inc. |
Spiro-condensed indole derivatives as sodium channel inhibitors
|
ES2623794T3
(es)
|
2008-12-09 |
2017-07-12 |
Gilead Sciences, Inc. |
Intermedios para la preparación de moduladores de receptores tipo toll
|
US20110237633A1
(en)
|
2008-12-11 |
2011-09-29 |
Bijoy Panicker |
Small molecule modulators of hepatocyte growth factor (scatter factor) activity
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
CA2757415C
(en)
|
2009-04-02 |
2018-02-06 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
EA201101400A1
(ru)
|
2009-04-02 |
2012-07-30 |
Мерк Патент Гмбх |
Производные пиперидина и пиразина в качестве ингибиторов аутотаксина
|
WO2011003418A1
(en)
|
2009-07-08 |
2011-01-13 |
Leo Pharma A/S |
Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
|
RU2016108987A
(ru)
|
2009-08-18 |
2018-11-26 |
Вентиркс Фармасьютикалз, Инк. |
Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
|
EP3225623A1
(en)
|
2009-08-18 |
2017-10-04 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
KR101818779B1
(ko)
|
2009-09-21 |
2018-01-15 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료용 2'―플루오로 치환된 카바-뉴클레오사이드 유사체
|
WO2011048611A1
(en)
|
2009-10-07 |
2011-04-28 |
Torrent Pharmaceuticals Limited |
Novel fused pyridazine derivatives
|
PE20121091A1
(es)
|
2009-10-22 |
2012-08-17 |
Gilead Sciences Inc |
Derivados de purina o deazapurina utiles en el tratamiento de (inter alia) infecciones virales
|
US20110178104A1
(en)
|
2010-01-07 |
2011-07-21 |
Polymedix Inc. |
Anti-Heparin Compounds
|
JPWO2011087051A1
(ja)
|
2010-01-14 |
2013-05-20 |
国立大学法人金沢大学 |
S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
JP5944837B2
(ja)
|
2010-03-18 |
2016-07-05 |
インスティチュート・パスツール・コリアInstitut Pasteur Korea |
抗感染化合物
|
US8871799B2
(en)
|
2010-04-23 |
2014-10-28 |
Kineta, Inc. |
Iminochromene anti-viral compounds
|
WO2011133722A2
(en)
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Anti-viral compounds
|
AR081039A1
(es)
|
2010-05-14 |
2012-05-30 |
Osi Pharmaceuticals Llc |
Inhibidores biciclicos fusionados de quinasa
|
WO2011146401A1
(en)
|
2010-05-17 |
2011-11-24 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
WO2011145669A1
(ja)
|
2010-05-19 |
2011-11-24 |
大日本住友製薬株式会社 |
アミド誘導体
|
RS55184B1
(sr)
|
2010-05-31 |
2017-01-31 |
Ono Pharmaceutical Co |
Derivat purinona kao inhibitor btk kinaze
|
WO2012016186A1
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Macrocyclic kinase inhibitors and uses thereof
|
CA2807097A1
(en)
|
2010-07-30 |
2012-02-02 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
WO2012020567A1
(en)
|
2010-08-09 |
2012-02-16 |
Raqualia Pharma Inc. |
Acyl piperazine derivatives as ttx-s blockers
|
EP2611808B1
(en)
|
2010-09-02 |
2014-11-12 |
Merck Patent GmbH |
Pyrazolopyridinone derivatives as lpa receptor antagonists
|
WO2012038942A1
(en)
|
2010-09-24 |
2012-03-29 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
WO2012050868A1
(en)
|
2010-09-28 |
2012-04-19 |
Georgia Tech Research Corporation |
Histone deacetylase (hdac) inhibitors targeting prostate tumors and methods of making and using thereof
|
SG10201601089UA
(en)
|
2010-10-01 |
2016-03-30 |
Ventirx Pharmaceuticals Inc |
Therapeutic Use Of A TLR Agonist And Combination Therapy
|
BR112013007678A2
(pt)
|
2010-10-01 |
2017-07-04 |
Ventirx Pharmaceuticals Inc |
método para tratamento de doenças alérgicas
|
US9273028B2
(en)
|
2010-10-29 |
2016-03-01 |
Biogen Ma Inc. |
Heterocyclic tyrosine kinase inhibitors
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
HUE032638T2
(en)
|
2011-01-12 |
2017-10-30 |
Ventirx Pharmaceuticals Inc |
Toll receptor modulator substituted benzoazepines
|
DK2663550T3
(en)
|
2011-01-12 |
2017-03-27 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
AU2012217616B2
(en)
|
2011-02-18 |
2017-03-02 |
Vertex Pharmaceuticals Incorporated |
Chroman - spirocyclic piperidine amides as modulators of ion channels
|
US9295754B2
(en)
|
2011-02-24 |
2016-03-29 |
Emory University |
Noggin inhibitory compositions for ossification and methods related thereto
|
EP2685976B1
(en)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
LT2694484T
(lt)
|
2011-04-08 |
2018-10-10 |
Janssen Sciences Ireland Uc |
Pirimidino dariniai, skirti virusinių infekcijų gydymui
|
JP5833745B2
(ja)
|
2011-05-16 |
2015-12-16 |
セルシューティクス・コーポレーション |
粘膜炎の治療に使用するための化合物
|
US9156830B2
(en)
|
2011-05-17 |
2015-10-13 |
Shionogi & Co., Ltd. |
Heterocyclic compounds
|
MX347966B
(es)
|
2011-05-18 |
2017-05-18 |
Janssen Sciences Ireland Uc |
Derivados de quinazolina para el tratamiento de infecciones viricas y otras enfermedades.
|
ES2700470T3
(es)
|
2011-05-19 |
2019-02-15 |
Gilead Sciences Inc |
Procesos e intermediarios para la preparación de agentes anti-VIH
|
KR20140041519A
(ko)
|
2011-06-07 |
2014-04-04 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
인다졸-유도체 및 피롤로피리딘-유도체 및 그의 약제학적 용도
|
JP5977347B2
(ja)
*
|
2011-07-01 |
2016-08-24 |
バルーク エス.ブルームバーグ インスティテュート |
Hbv感染に対する抗ウイルス剤としてのスルファモイルベンズアミド誘導体
|
TWI454466B
(zh)
|
2011-07-22 |
2014-10-01 |
Ken Tsung Wong |
可用於有機薄膜太陽能電池之化合物及有機薄膜太陽能電池
|
US9780311B2
(en)
|
2011-07-29 |
2017-10-03 |
Merck Patent Gmbh |
Compounds for electronic devices
|
AU2012311061B2
(en)
|
2011-09-23 |
2016-08-18 |
Advinus Therapeutics Limited |
Amide compounds, compositions and applications thereof
|
CN104024249A
(zh)
|
2011-10-17 |
2014-09-03 |
埃南塔制药公司 |
丙型肝炎病毒抑制剂
|
TW201329078A
(zh)
|
2011-11-29 |
2013-07-16 |
Ono Pharmaceutical Co |
嘌呤酮衍生物鹽酸鹽
|
EP2787990A4
(en)
|
2011-12-05 |
2015-09-02 |
Univ Brandeis |
TREATMENT OF AMYLOID DOSE BY MEANS OF COMPOUNDS THAT REGULATE THE STABILIZATION OF RETROMERS
|
DE102011121022A1
(de)
|
2011-12-13 |
2013-06-13 |
Merck Patent Gmbh |
Organische Sensibilisatoren für Up- Conversion
|
CA2857344C
(en)
|
2011-12-21 |
2019-02-12 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
KR102064807B1
(ko)
|
2012-02-08 |
2020-01-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염을 치료하기 위한 피페리디노-피리미딘 유도체
|
WO2013144228A1
(en)
|
2012-03-29 |
2013-10-03 |
Basf Se |
Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
EP2831060B1
(en)
|
2012-03-31 |
2016-05-04 |
F.Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
JPWO2013161871A1
(ja)
|
2012-04-25 |
2015-12-24 |
興和株式会社 |
Tlr阻害作用を有するチオフェン誘導体
|
MX2014014766A
(es)
|
2012-06-08 |
2015-05-11 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae.
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
MX2014014768A
(es)
|
2012-06-08 |
2015-05-11 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae.
|
CN104781239B
(zh)
|
2012-08-10 |
2019-03-01 |
爱尔兰詹森科学公司 |
用于治疗病毒感染和另外的疾病的烷基嘧啶衍生物
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
WO2014033167A1
(en)
|
2012-08-28 |
2014-03-06 |
Janssen R&D Ireland |
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
CR20210079A
(es)
|
2012-08-28 |
2021-06-10 |
Janssen Sciences Ireland Uc |
Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
|
WO2014039595A1
(en)
|
2012-09-06 |
2014-03-13 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
MA37942B1
(fr)
|
2012-09-10 |
2020-01-31 |
Hoffmann La Roche |
Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
|
IN2015DN02008A
(es)
|
2012-09-21 |
2015-08-14 |
Advinus Therapeutics Ltd |
|
SG11201502452RA
(en)
|
2012-10-02 |
2015-05-28 |
Epitherapeutics Aps |
Inhibitors of histone demethylases
|
CA2884478C
(en)
|
2012-10-10 |
2021-02-16 |
Janssen Sciences Ireland Uc |
Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
|
ES2655843T3
(es)
|
2012-11-16 |
2018-02-21 |
Janssen Sciences Ireland Uc |
Derivados 2-aminoquinazolínicos sustituidos heterocíclicos para el tratamiento de infecciones víricas
|
EP2928471B1
(en)
|
2012-12-06 |
2020-10-14 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
CN104918612B
(zh)
|
2012-12-06 |
2019-10-25 |
巴鲁克斯布隆伯格研究所 |
作为抗hbv感染的抗病毒剂的官能化苯甲酰胺衍生物
|
JP2014133739A
(ja)
|
2012-12-12 |
2014-07-24 |
Dainippon Sumitomo Pharma Co Ltd |
インダゾール誘導体またはピロロピリジン誘導体からなる医薬
|
US9617242B2
(en)
|
2012-12-19 |
2017-04-11 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
AU2013363957B2
(en)
|
2012-12-21 |
2018-03-22 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
MX2015007921A
(es)
|
2012-12-21 |
2016-03-03 |
Zenith Epigenetics Corp |
Compuestos heterociclicos novedosos como inhibidores de bromodominio.
|
ES2660288T3
(es)
|
2012-12-24 |
2018-03-21 |
Cadila Healthcare Limited |
Derivados de quinolona
|
EA201591220A1
(ru)
|
2012-12-27 |
2016-01-29 |
Дрексел Юниверсити |
Новые противовирусные агенты против инфекции вирусом гепатита в
|
US9040504B2
(en)
|
2013-01-10 |
2015-05-26 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
KR102275616B1
(ko)
|
2013-01-29 |
2021-07-09 |
레드엑스 파마 피엘씨 |
연성 rock 저해제로서 피리딘 유도체
|
GB201303109D0
(en)
|
2013-02-21 |
2013-04-10 |
Domainex Ltd |
Novel pyrimidine compounds
|
DK2958900T3
(da)
|
2013-02-21 |
2019-07-01 |
Janssen Sciences Ireland Unlimited Co |
2-aminopyrimidinderivater til behandling af virusinfektioner
|
EA030451B1
(ru)
|
2013-02-27 |
2018-08-31 |
Эпитерапьютикс Апс |
Ингибиторы гистондеметилаз
|
CA2899706C
(en)
|
2013-02-28 |
2021-10-19 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
WO2014164708A1
(en)
|
2013-03-12 |
2014-10-09 |
Quanticel Pharmaceuticals, Inc. |
Histone dementhylase inhibitors
|
US10035801B2
(en)
|
2013-03-13 |
2018-07-31 |
Genentech, Inc. |
Pyrazolo compounds and uses thereof
|
EP2970340B1
(en)
|
2013-03-14 |
2020-02-12 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
US9527829B2
(en)
|
2013-03-14 |
2016-12-27 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
RS56561B1
(sr)
|
2013-03-15 |
2018-02-28 |
Quanticel Pharmaceuticals Inc |
Inhibitori histon demetilaze
|
DK2981536T3
(en)
|
2013-04-03 |
2017-09-25 |
Janssen Sciences Ireland Uc |
N-PHENYLC CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
|
WO2014179144A1
(en)
|
2013-04-29 |
2014-11-06 |
E. I. Du Pont De Nemours And Company |
Fungicidal heterocyclic compounds
|
CA2911214A1
(en)
|
2013-05-17 |
2014-11-20 |
F. Hoffmann-La Roche Ag |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
PT2997019T
(pt)
|
2013-05-17 |
2018-11-21 |
Janssen Sciences Ireland Uc |
Derivados de sulfamoíltiofenamida e o seu uso como medicamentos para o tratamento da hepatite b
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
EP3013797B1
(en)
|
2013-06-28 |
2018-01-03 |
BeiGene, Ltd. |
Fused tricyclic amide compounds as multiple kinase inhibitors
|
US9637487B2
(en)
|
2013-07-02 |
2017-05-02 |
Pharmacyclics Llc |
Purinone compounds as kinase inhibitors
|
CA2935719C
(en)
*
|
2013-07-25 |
2021-11-02 |
Janssen Sciences Ireland Uc |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015026935A2
(en)
|
2013-08-20 |
2015-02-26 |
City Of Hope |
Hdac8 inhibitors for treating cancer
|
KR101715090B1
(ko)
|
2013-08-28 |
2017-03-13 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
WO2015051230A1
(en)
|
2013-10-04 |
2015-04-09 |
Drexel University |
Novel compositions useful for inhibiting hiv-1 infection and methods using same
|
WO2015057945A1
(en)
|
2013-10-18 |
2015-04-23 |
Indiana University Research And Technology Corporation |
Hepatitis b viral assembly effectors
|
US10047070B2
(en)
|
2013-10-18 |
2018-08-14 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
CA2923712C
(en)
|
2013-10-23 |
2021-11-02 |
Janssen Sciences Ireland Uc |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015073774A1
(en)
|
2013-11-14 |
2015-05-21 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis b infections
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
AU2015212903A1
(en)
|
2014-01-30 |
2016-05-19 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
|
US20150216938A1
(en)
|
2014-02-05 |
2015-08-06 |
Novira Therapeutics Inc. |
Combination therapy for treatment of hbv infections
|
US11078193B2
(en)
|
2014-02-06 |
2021-08-03 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
CN106456602B
(zh)
|
2014-03-27 |
2020-11-24 |
范德比尔特大学 |
取代的吲哚mcl-1抑制剂
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
RU2016146365A
(ru)
|
2014-05-13 |
2018-06-19 |
Ф. Хоффманн-Ля Рош Аг |
Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b
|
WO2015180631A1
(zh)
|
2014-05-30 |
2015-12-03 |
南京明德新药研发股份有限公司 |
作为hbv抑制剂的二氢嘧啶并环衍生物
|
EP3169683A4
(en)
|
2014-07-16 |
2017-11-22 |
Novogen Ltd. |
Functionalised and substituted indoles as anti-cancer agents
|
BR112017002970B1
(pt)
|
2014-08-14 |
2023-04-11 |
F. Hoffmann-La Roche Ag |
Novas piridazonas e triazinonas para o tratamento e profilaxia da infecção pelo vírus da hepatite b
|
BR112017002811B1
(pt)
|
2014-08-15 |
2022-09-06 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Compostos de pirrolopirimidina usados como agonista de tlr7 e seu uso, composição farmacêutica e kit
|
EA201790154A1
(ru)
|
2014-08-27 |
2017-08-31 |
Джилид Сайэнс, Инк. |
Соединения и способы для ингибирования гистоновых деметилаз
|
CN107912040B
(zh)
|
2014-10-10 |
2021-04-06 |
基因泰克公司 |
作为组蛋白脱甲基酶抑制剂的吡咯烷酰胺化合物
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
EP3242878B1
(en)
|
2015-01-08 |
2020-10-14 |
Impetis Biosciences Ltd. |
Bicyclic compounds, compositions and medicinal applications thereof
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
WO2016128908A1
(en)
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
WO2016189129A1
(de)
|
2015-05-28 |
2016-12-01 |
Basf Se |
Verfahren zur homogen katalysierten reduktiven aminierung von carbonyl-verbindungen
|
WO2016201440A1
(en)
|
2015-06-12 |
2016-12-15 |
The Regents Of The University Of California |
Spiroindolinones and therapeutic uses thereof
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
JP6732008B2
(ja)
|
2015-07-20 |
2020-07-29 |
浙江中科▲創▼越▲薬▼▲業▼有限公司 |
シュウ酸アミド系配位子および銅触媒によるハロゲン化アリールのカップリング反応におけるその使用
|
WO2017015451A1
(en)
|
2015-07-22 |
2017-01-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
US10029995B2
(en)
|
2015-09-03 |
2018-07-24 |
Forma Therapeutics, Inc. |
[6,6] fused bicyclic HDAC8 inhibitors
|
GB201516614D0
(en)
|
2015-09-18 |
2015-11-04 |
Redx Pharma Plc |
Antibacterial compounds
|
US10676478B2
(en)
|
2015-11-05 |
2020-06-09 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
|
JP6621933B2
(ja)
|
2015-11-09 |
2019-12-18 |
ギリアード サイエンシス インコーポレーテッド |
ヒト免疫不全ウイルスを処置するための治療組成物
|
WO2017114512A1
(zh)
|
2015-12-31 |
2017-07-06 |
上海医药集团股份有限公司 |
含氮稠杂环化合物、制备方法、中间体、组合物和应用
|
SG11201807569WA
(en)
*
|
2016-03-09 |
2018-10-30 |
Univ Emory |
Elimination of hepatitis b virus with antiviral agents
|
CN114539284A
(zh)
|
2016-03-16 |
2022-05-27 |
库拉肿瘤学公司 |
经取代的menin-mll抑制剂及使用方法
|
WO2017161524A1
(zh)
|
2016-03-23 |
2017-09-28 |
华东理工大学 |
丙酮酸脱氢酶激酶抑制剂及其应用
|
CN107226805A
(zh)
|
2016-03-24 |
2017-10-03 |
北京天诚医药科技有限公司 |
芳香族酰胺类衍生物、其制备方法及其在医药上的应用
|
AU2017240685B2
(en)
|
2016-03-31 |
2021-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
WO2017209265A1
(ja)
|
2016-06-03 |
2017-12-07 |
塩野義製薬株式会社 |
二環性複素環誘導体およびそれらを含有する医薬組成物
|
MX2018015315A
(es)
|
2016-06-10 |
2019-04-25 |
Enanta Pharm Inc |
Agentes antivirales contra la hepatitis b.
|
CN107537157B
(zh)
|
2016-06-29 |
2022-05-17 |
无敌媒体有限公司 |
用于减少具有虚拟货币的电子游戏中的欺诈的系统和方法
|
JOP20190024A1
(ar)
*
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
CN111788204B
(zh)
*
|
2018-02-26 |
2023-05-05 |
吉利德科学公司 |
作为hbv复制抑制剂的取代吡咯嗪化合物
|